MoonsAH,LeviM,PetersRJ, 2002.Tissue factor and coronary artery disease,Cardiovascular Res 53 313 -25
CimminoG,GolinoP,BadimonJJ, 2011.Pathophysiological role of bloodborne tissue factor: should the old paradigm be revisited?,Intern Emerg Med 6 29 -34
OwensAP,MackmanN., 2011.Microparticles in hemostasis and thrombosis,Circ Res 108 1284 -97
ToschiV,GalloR,LettinoM,FallonJT,GertzSD,Fernandez-OrtizA, 1997.modulates the thrombogenicity of human atheroscl eroti c plaques,Ci rcul ation 95 594 -9
LeroyerAS,IsobeH,LesecheG,CastierY,WassefM,MallatZ, 2007.Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques,J Am Coll Cardiol 49 772 -77
PirilloA,NorataGD,CatapanoAL, 2013.LOX-1, OxLDL, and atherosclerosis,Mediators Inflamm 152786 -
MeiselSR,XuXP,EdgingtonTS,CercekB,OngJ,KaulS, 2011.Dosedependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein,J Atheroscler Thromb 18 596 -603
LiP,YangY,LiuM, 2011.Xuezhikang, extract of red yeast rice, inhibited tissue factor and hypercoagulable state through suppressing nicotinamide adenine dinucleotide phosphate oxidase and extracellular signal-regulated kinase activation,J Cardiovasc Pharmacol 58 307 -18
HongDP,HagiharaY,KatoH,GotoY., 2001.Flexible loop of beta 2- glycoprotein I domain V specifically interacts with hydrophobic ligands,Biochem 40 8092 -100
MatsuuraE,InagakiJ,KasaharaH,YamamotoD,AtsumiT,KobayashiK, 2000.Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship,Int Immunol 12 1183 -92
ZhangY,LiW,ChiY,WangR,WangD,ZhangF, 2011.Recombinant domain V of beta2-glycoprotein I inhibits the formation of a 7- ketocholesteryl-9-carboxynonanoate and beta2-glycoprotein I complex,J Biochem 149 35 -42
LiJ,ChiY,LiuS,WangL,WangR,HanX,GlycoproteinI Complexes. J Clin,Immunol, 2014.Recombinant Domain V of beta2-Glycoprotein I Inhibits the Formation of Atherogenic oxLDL/beta2-, 34 669 -76
ChiY,WangL,LiuY,MaY,WangR,HanX, 2014.-ketocholesteryl-9- carboxynonanoate enhances ATP binding cassette transporter A1 expression mediated by PPARgamma in THP-1 macrophages, 234 461 -68
LiYD,YeBQ,ZhengSX,WangJT,WangJG,ChenM, 2009.NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis,J Biol Chem 284 4473 -83
RobbesynF,SalvayreR,Negre-SalvayreA, 2004.Dual role of oxidized LDL on the NF-kappaB signaling pathway,Free Radic Res 38 541 -51
RadhikaA,SudhakaranPR, 2013.Upregulation of macrophage-specific functions by oxidized LDL: lysosomal degradation-dependent and -independent pathways,Mol Cell Biochem 372 181 -90
NagyL,TontonozP,AlvarezJG,ChenH,EvansRM, 1998.Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma,Cell 93 229 -40
KugeY,KumeN,IshinoS,TakaiN,OgawaY,MukaiT, 2008.Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits,Biol Pharm Bull 31 1475 -82
GrecoTP,Conti-KellyAM,AnthonyJR,GrecoT,DoyleR,BoisenMK, 2010.Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes,Am J Clin Pathol 133 737 -43
KobayashiK,KishiM,AtsumiT,BertolacciniML,MakinoH,SakairiN, 2003.Circulating oxidized LDL forms complexes with beta2- glycoprotein I: implication as an atherogenic autoantigen,J lipid Res 44 716 -26
LopezLR,BucknerTR,HurleyBL,KobayashiK,MatsuuraE.,Y AcadSci, 2007.Determination of oxidized low-density lipoproteins (ox-LDL) versus ox-LDL/beta2GPI complexes for the assessment of autoimmunemediated atherosclerosis, 1109 303 -10
HasunumaY,MatsuuraE,MakitaZ,KatahiraT,NishiS,KoikeT., 1997.Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages,Clin Exper Immunol 107 569 -73
LinKY,PanJP,YangDL,HuangKT,ChangMS,DingPY,-glycoproteinI). Life,Sci, 2001.Evidence for inhibition of low density lipoprotein oxidation and cholesterol accumulation by apolipoprotein H (beta2, 69 707 -19
ChistiakovDA,OrekhovAN,BobryshevYV, 2016.LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis,Cell Physiol Biochem 38 1851 -9